Skip to main content
SpringerLink
Log in

Gender issues and multiple sclerosis

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Gender-related issues in multiple sclerosis include the important and widely accepted clinical observations that men are less susceptible to the disease than women and also that disease activity in multiple sclerosis is decreased during late pregnancy. This article reviews mechanisms underlying each of these clinical observations and discusses the role of sex hormones in each. Specifically, the protective role of testosterone in young men and the protective role of the pregnancy hormone estriol in pregnant women are discussed. Rationale for novel therapies in multiple sclerosis based on the protective roles of these sex hormones is presented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Barkhof F, van WaesbergheJH, Filippi M, et al.: T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment. Brain 2001, 124:1396–1402.

    Article  PubMed  CAS  Google Scholar 

  2. Trapp BD, Ransohoff R, Rudick R: Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 1999, 12:295–302.

    Article  PubMed  CAS  Google Scholar 

  3. de JongBA, Schrijver HM, Huizinga TW, et al.: Innate production of interleukin-10 and tumor necrosis factor affects the risk of multiple sclerosis. Ann Neurol 2000, 48:641–646.

    Article  PubMed  Google Scholar 

  4. Clinical demographics of multiplex families with multiple sclerosis. Multiple Sclerosis Genetics Group. Ann Neurol 1998, 43:530–534.

    Article  Google Scholar 

  5. Weinshenker BG: Natural history of multiple sclerosis. Ann Neurol 1994, 36:S6–11.

    Article  PubMed  Google Scholar 

  6. Thompson AJ, Kermode AG, Wicks D, et al.: Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991, 29:53–62.

    Article  PubMed  CAS  Google Scholar 

  7. Lucchinetti C, Bruck W, Parisi J, et al.: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000, 47:707–717.

    Article  PubMed  CAS  Google Scholar 

  8. Hupperts R, Broadley S, Mander A, et al.: Patterns of disease in concordant parent-child pairs with multiple sclerosis. Neurology 2001, 57:290–295.

    PubMed  CAS  Google Scholar 

  9. Bashir K, Whitaker JN: Clinical and laboratory features of primary progressive and secondary progressive MS. Neurology 1999, 53:765–771.

    PubMed  CAS  Google Scholar 

  10. Abramsky O: Pregnancy and multiple sclerosis. Ann Neurol 1994, 36(suppl):S38–41.

    Article  PubMed  Google Scholar 

  11. Bijlsma JW, Van den BrinkHR: Estrogens and rheumatoid arthritis. Am J Reproductive Immunol 1992, 28:231–234.

    CAS  Google Scholar 

  12. Da SilvaJA, Spector TD: The role of pregnancy in the course and aetiology of rheumatoid arthritis. Clin Rheumatol 1992, 11:189–194.

    Article  PubMed  Google Scholar 

  13. Da SilvaJA, Hall GM: The effects of gender and sex hormones on outcome in rheumatoid arthritis. Baillieres Clin Rheumatol 1992, 6:196–219.

    PubMed  Google Scholar 

  14. Jungers P, Dougados M, Pélissier C, et al.: Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. Arch Intern Med 1982, 142:771–776.

    Article  PubMed  CAS  Google Scholar 

  15. Jungers P, Dougados M, Pélissier C, et al.: Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum 1982, 25:618–623.

    Article  PubMed  CAS  Google Scholar 

  16. Smith R, Studd JW: A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J Royal Soc Med 1992, 85:612–613.

    CAS  Google Scholar 

  17. Van VollenhovenRF, McGuire JL: Estrogen, progesterone, and testosterone: can they be used to treat autoimmune diseases? Cleveland Clin J Med 1994, 61:276–284.

    Google Scholar 

  18. Villard-Mackintosh L, Vessey MP: Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 1993, 47:161–168.

    Article  PubMed  CAS  Google Scholar 

  19. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? [comment]. Immunology Today 1993, 14:353–356.

    Article  PubMed  CAS  Google Scholar 

  20. Blackman MR: Unpublished data from the Baltimore Longitudinal Study.

  21. Gray A, Berlin JA, McKinlay JB, Longcope C: An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. J Clin Epidemiol 1991, 44:671–684.

    Article  PubMed  CAS  Google Scholar 

  22. Morley JE, Kaiser FE, Perry HM 3rd, et al.: Longitudinal changes in testosterone, luteinizing hormone, and folliclestimulating hormone in healthy older men. Clin Exper Metab 1997, 46:410–413.

    CAS  Google Scholar 

  23. Nankin HR, Calkins JH: Decreased bioavailable testosterone in aging normal and impotent men. J Clin Endocrinol Metab 1986, 63:1418–1420.

    PubMed  CAS  Google Scholar 

  24. Tenover JS, Matsumoto AM, Plymate SR, Bremner WJ: The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate. J Clin Endocrinol Metab 1987, 65:1118–1126.

    PubMed  CAS  Google Scholar 

  25. Vermeulen A: Clinical review 24: Androgens in the aging male. J Clin Endocrinol Metab 1991, 73:221–224.

    Article  PubMed  CAS  Google Scholar 

  26. Fox HS: Androgen treatment prevents diabetes in nonobese diabetic mice. J Exper Med 1992, 175:1409–1412.

    Article  CAS  Google Scholar 

  27. Ahmed SA, Penhale WJ: The influence of testosterone on the development of autoimmune thyroiditis in thymectomized and irradiated rats. Clin Exper Immunol 1982, 48:367–374.

    CAS  Google Scholar 

  28. Harbuz MS, Perveen-Gill Z, Lightman SL, Jessop DS: A protective role for testosterone in adjuvant-induced arthritis. Br J Rheumatol 1995, 34:1117–1122.

    Article  PubMed  CAS  Google Scholar 

  29. Ariga H, Edwards J, Sullivan DA: Androgen control of autoimmune expression in lacrimal glands of MRL/Mp-lpr/ lpr mice. Clin Immunol Immunopathol 1989, 53:499–508.

    Article  PubMed  CAS  Google Scholar 

  30. Sato EH, Ariga H, Sullivan DA: Impact of androgen therapy in Sjögren’s syndrome: hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/Mp-lpr/lpr mice. Invest Ophthalmol Visual Sci 1992, 33:2537–2545.

    CAS  Google Scholar 

  31. Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK: Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exper Med 1978, 147:1568–1583.

    Article  CAS  Google Scholar 

  32. Voskuhl RR, Pitchekian-Halabi H, MacKenzie-Graham A, McFarland HF, Raine CS: Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Ann Neurol 1996, 39:724–733.

    Article  PubMed  CAS  Google Scholar 

  33. Dalal M, Kim S, Voskuhl RR: Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J Immunol 1997, 159:3–6.

    PubMed  CAS  Google Scholar 

  34. Kim S, Voskuhl RR: Decreased IL-12 production underlies the decreased ability of male lymph node cells to induce experimental autoimmune encephalomyelitis. J Immunol 1999, 162:5561–5568.

    PubMed  CAS  Google Scholar 

  35. Cua DJ, Hinton DR, Stohlman SA: Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J Immunol 1995, 155:4052–4059.

    PubMed  CAS  Google Scholar 

  36. Bebo BFJr, Vandenbark AA, Offner H: Male SJL mice do not relapse after induction of EAE with PLP 139-151. J Neurosci Res 1996, 45:680–689.

    Article  PubMed  CAS  Google Scholar 

  37. Ando DG, Clayton J, Kono D, Urban JL, Sercarz EE: Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol 1989, 124:132–143.

    Article  PubMed  CAS  Google Scholar 

  38. Powell MB, Mitchell D, Lederman J, et al.: Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int Immunol 1990, 2:539–544.

    Article  PubMed  CAS  Google Scholar 

  39. Kennedy MK, Torrance DS, Picha KS, Mohler KM: Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992, 149:2496–2505.

    PubMed  CAS  Google Scholar 

  40. Crisi GM, Santambrogio L, Hochwald GM, et al.: Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-beta and interleukin-10. Eur J Immunol 1995, 25:3035–3040.

    Article  PubMed  CAS  Google Scholar 

  41. Rott O, Fleischer B, Cash E: Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 1994, 24:1434–1440.

    Article  PubMed  CAS  Google Scholar 

  42. Cannella B, Cross AH, Raine CS: Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J Exper Med 1990, 172:1521–1524.

    Article  CAS  Google Scholar 

  43. Bettelli E, Das MP, Howard ED, et al.: IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 1998, 161:3299–3306.

    PubMed  CAS  Google Scholar 

  44. Whitacre CC, Reingold SC, O’Looney PA: A gender gap in autoimmunity. Science 1999, 283:1277–1278. A review article on gender and autoimmunity.

    Article  PubMed  CAS  Google Scholar 

  45. Bebo BFJr, Zelinka-Vincent E, Adamus G, et al.: Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 1998, 84:122–130.

    Article  PubMed  CAS  Google Scholar 

  46. Voskuhl RR, Palaszynski K: Sex hormones and experimental autoimmune encephalomyelitis: implications for multiple sclerosis. The Neuroscientist 2001, 7:258–270.

    PubMed  CAS  Google Scholar 

  47. Liva SM, Voskuhl RR: Testosterone acts directly on CD4+ T-lymphocytes to increase IL10 production. J Immunol 2001, 167:2060–2067. Cellular mechanisms underlying the protective effect of testosterone are delineated.

    PubMed  CAS  Google Scholar 

  48. Bebo BFJr, Adlard K, Schuster JC, et al.: Gender differences in protection from EAE induced by oral tolerance with a peptide analogue of MBP-Ac1-11. J Neurosci Res 1999, 55:432–440.

    Article  PubMed  Google Scholar 

  49. Birk K, Ford C, Smeltzer S, et al.: The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch Neurol 1990, 47:738–742.

    PubMed  CAS  Google Scholar 

  50. Birk K, Smeltzer SC, Rudick R: Pregnancy and multiple sclerosis. Semin Neurol 1988, 8:205–213.

    PubMed  CAS  Google Scholar 

  51. Runmarker B, Andersen O: Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis [comment]. Brain 1995, 118:253–261.

    Article  PubMed  Google Scholar 

  52. Confavreux C, Hutchinson M, Hours MM, Cortinovis- Tourniaire P, Moreau T: Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group [comment]. N Engl J Med 1998, 339:285–291.

    Article  PubMed  CAS  Google Scholar 

  53. van WalderveenMA, Tas MW, Barkhof F, et al.: Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis. Neurology 1994, 44:327–329.

    PubMed  Google Scholar 

  54. Amino N, Tada H, Hidaka Y: Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. Thyroid 1999, 9:705–713.

    PubMed  CAS  Google Scholar 

  55. Terry AJ, Hague WM: Postpartum thyroiditis. Semin Perinatol 1998, 22:497–502.

    Article  PubMed  CAS  Google Scholar 

  56. Formby B: Immunologic response in pregnancy. Its role in endocrine disorders of pregnancy and influence on the course of maternal autoimmune diseases. Endocrinol Metab Clin North Am 1995, 24:187–205.

    PubMed  CAS  Google Scholar 

  57. Hill JA, Polgar K, Anderson DJ: T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion [comment]. JAMA 1995, 273:1933–1936.

    Article  PubMed  CAS  Google Scholar 

  58. Krishnan L, Guilbert LJ, Wegmann TG, Belosevic M, Mosmann TR: T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells. J Immunol 1996, 156:653–662.

    PubMed  CAS  Google Scholar 

  59. Marzi M, Vigano A, Trabattoni D, et al.: Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exper Immunol 1996, 106:127–133.

    Article  CAS  Google Scholar 

  60. Raghupathy R: Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997, 18:478–482.

    Article  PubMed  CAS  Google Scholar 

  61. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG: Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993, 151:4562–4573.

    PubMed  CAS  Google Scholar 

  62. Sacks GP, Clover LM, Bainbridge DR, Redman CW, Sargent IL: Flow cytometric measurement of intracellular Th1 and Th2 cytokine production by human villous and extravillous cytotrophoblast. Placenta 2001, 22:550–559.

    Article  PubMed  CAS  Google Scholar 

  63. Dudley DJ, Chen CL, Mitchell MD, Daynes RA, Araneo BA: Adaptive immune responses during murine pregnancy: pregnancy-induced regulation of lymphokine production by activated T lymphocytes. Am J Obstet Gynecol 1993, 168:1155–1163.

    PubMed  CAS  Google Scholar 

  64. Elenkov IJ, Wilder RL, Bakalov VK, et al.: IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 2001, 86:4933–4938.

    Article  PubMed  CAS  Google Scholar 

  65. Fabris N, Piantanelli L, Muzzioli M: Differential effect of pregnancy or gestagens on humoral and cell-mediated immunity. Clin Exper Immunol 1977, 28:306–314.

    CAS  Google Scholar 

  66. Krishnan L, Guilbert LJ, Russell AS, et al.: Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines. J Immunol 1996, 156:644–652.

    PubMed  CAS  Google Scholar 

  67. Jansson L, Olsson T, Holmdahl R: Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J Neuroimmunol 1994, 53:203–207.

    Article  PubMed  CAS  Google Scholar 

  68. Jansson L, Mattsson A, Mattsson R, Holmdahl R: Estrogen induced suppression of collagen arthritis. V: Physiological level of estrogen in DBA/1 mice is therapeutic on established arthritis, suppresses anti-type II collagen T-cell dependent immunity and stimulates polyclonal B-cell activity. J Autoimmunity 1990, 3:257–270.

    Article  CAS  Google Scholar 

  69. Jansson L, Holmdahl R: Oestrogen-induced suppression of collagen arthritis; 17 beta-oestradiol is therapeutically active in normal and castrated F1 hybrid mice of both sexes. Clin Exper Immunol 1992, 89:446–451.

    Article  CAS  Google Scholar 

  70. Kim S, Liva SM, Dalal MA, Verity MA, Voskuhl RR: Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 1999, 52:1230–1238. Mechanisms of the protective effect of treatment with estriol in relapsing experimental autoimmune encephalomyelitis (EAE) are demonstrated.

    Article  PubMed  CAS  Google Scholar 

  71. Jansson L, Holmdahl R: Oestrogen induced suppression of collagen arthritis. IV: Progesterone alone does not affect the course of arthritis but enhances the oestrogen-mediated therapeutic effect. J Reproductive Immunol 1989, 15:141–150.

    Article  CAS  Google Scholar 

  72. Correale J, Arias M, Gilmore W: Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1998, 161:3365–3374.

    PubMed  CAS  Google Scholar 

  73. Gilmore W, Weiner LP, Correale J: Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1997, 158:446–451.

    PubMed  CAS  Google Scholar 

  74. Bebo BF Jr, Fyfe-Johnson A, Adlard K, et al.: Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol 2001, 166:2080–2089.

    PubMed  CAS  Google Scholar 

  75. Matejuk A, Adlard K, Zamora A, et al.: 17beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J Neurosci Res 2001, 65:529–542.

    Article  PubMed  CAS  Google Scholar 

  76. Hernan MA, Hohol MJ, Olek MJ, Spiegelman D, Ascherio A: Oral contraceptives and the incidence of multiple sclerosis. Neurology 2000, 55:848–854.

    PubMed  CAS  Google Scholar 

  77. Thorogood M, Hannaford PC: The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol 1998, 105:1296–1299.

    PubMed  CAS  Google Scholar 

  78. Sicotte N, Pfieffer P, Klutch R, et al.: Treatment of women with multiple sclerosis using the pregnancy hormone estriol: a pilot study. Neurology 2001, 56:A75.

    Google Scholar 

  79. Lauritzen C: Results of a 5 years prospective study of estriol succinate treatment in patients with climacteric complaints. Hormone Metab Res 1987, 19:579–584.

    Article  CAS  Google Scholar 

  80. Schiff I, Wentworth B, Koos B, Ryan KJ, Tulchinsky D: Effect of estriol administration on the hypogonadal woman. Fertility and Sterility 1978, 30:278–282.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UCLA Department of Neurology, Reed Neurological Research Center, Room A-145, 710 Westwood Plaza, 90024, Los Angeles, CA, USA

    Rhonda R. Voskuhl MD

Authors
  1. Rhonda R. Voskuhl MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Voskuhl, R.R. Gender issues and multiple sclerosis. Curr Neurol Neurosci Rep 2, 277–286 (2002). https://doi.org/10.1007/s11910-002-0087-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-002-0087-1

Keywords

Search

Navigation